Serum Institute of India (SII) will produce up to an additional 100 million COVID-19 vaccine doses for low and middle-income countries (LMICs) in 2021.
The company made this announcement taking forward the collaboration between SII, Gavi, Vaccine Alliance and Bill & Melinda Gates Foundation.
The collaboration will provide upfront capital to SII to help it increase manufacturing capacity.
